333 related articles for article (PubMed ID: 1637025)
1. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients.
Rosove MH; Brewer PM
Ann Intern Med; 1992 Aug; 117(4):303-8. PubMed ID: 1637025
[TBL] [Abstract][Full Text] [Related]
2. The management of thrombosis in the antiphospholipid-antibody syndrome.
Khamashta MA; Cuadrado MJ; Mujic F; Taub NA; Hunt BJ; Hughes GR
N Engl J Med; 1995 Apr; 332(15):993-7. PubMed ID: 7885428
[TBL] [Abstract][Full Text] [Related]
3. A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis.
Krnic-Barrie S; O'Connor CR; Looney SW; Pierangeli SS; Harris EN
Arch Intern Med; 1997 Oct; 157(18):2101-8. PubMed ID: 9382667
[TBL] [Abstract][Full Text] [Related]
4. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).
Finazzi G; Marchioli R; Brancaccio V; Schinco P; Wisloff F; Musial J; Baudo F; Berrettini M; Testa S; D'Angelo A; Tognoni G; Barbui T
J Thromb Haemost; 2005 May; 3(5):848-53. PubMed ID: 15869575
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis.
Wahl DG; Bounameaux H; de Moerloose P; Sarasin FP
Arch Intern Med; 2000 Jul; 160(13):2042-8. PubMed ID: 10888978
[TBL] [Abstract][Full Text] [Related]
6. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.
Ruiz-Irastorza G; Khamashta MA; Hunt BJ; Escudero A; Cuadrado MJ; Hughes GR
Arch Intern Med; 2002 May; 162(10):1164-9. PubMed ID: 12020188
[TBL] [Abstract][Full Text] [Related]
7. Management of antiphospholipid antibody syndrome: a systematic review.
Lim W; Crowther MA; Eikelboom JW
JAMA; 2006 Mar; 295(9):1050-7. PubMed ID: 16507806
[TBL] [Abstract][Full Text] [Related]
8. Thrombosis and antiphospholipid syndrome: a preliminary assessment of three antithrombotic treatments.
Rivier G; Herranz MT; Khamashta MA; Hughes GR
Lupus; 1994 Apr; 3(2):85-90. PubMed ID: 7920619
[TBL] [Abstract][Full Text] [Related]
9. [Recurrent thromboses and hemorrhagic complications in patients with antiphospholipid syndrome during therapy with warfarin plus aspirin].
Kondrat'eva LV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Kovalenko TF; Ostriakova EV; Reshetniak TM
Ter Arkh; 2010; 82(5):33-9. PubMed ID: 20597268
[TBL] [Abstract][Full Text] [Related]
10. [The antiphospholipid syndrome, an update].
Alonso Santor JE; Inglada Galiana L; Pérez Paredes G
An Med Interna; 2007 May; 24(5):242-8. PubMed ID: 17907891
[TBL] [Abstract][Full Text] [Related]
11. Longterm anticoagulation is preferable for patients with antiphospholipid antibody syndrome. result of a decision analysis.
Brunner HI; Chan WS; Ginsberg JS; Feldman BM
J Rheumatol; 2002 Mar; 29(3):490-501. PubMed ID: 11908562
[TBL] [Abstract][Full Text] [Related]
12. Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients.
Hereng T; Lambert M; Hachulla E; Samor M; Dubucquoi S; Caron C; Launay D; Morell-Dubois S; Queyrel V; Hatron PY
Lupus; 2008 Jan; 17(1):11-5. PubMed ID: 18089677
[TBL] [Abstract][Full Text] [Related]
13. Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS).
Cuadrado MJ; Bertolaccini ML; Seed PT; Tektonidou MG; Aguirre A; Mico L; Gordon C; Ruiz-Irastorza G; Egurbide MV; Gil A; Espinosa G; Houssiau F; Rahman A; Martin H; McHugh N; Galindo M; Akil M; Amigo MC; Murru V; Khamashta MA
Rheumatology (Oxford); 2014 Feb; 53(2):275-84. PubMed ID: 24097288
[TBL] [Abstract][Full Text] [Related]
14. [Aspirin and antiphospholipid syndrome].
Hachulla E; Piette AM; Hatron PY; Blétry O
Rev Med Interne; 2000 Mar; 21 Suppl 1():83s-88s. PubMed ID: 10763209
[TBL] [Abstract][Full Text] [Related]
15. Management of thrombosis in antiphospholipid antibody syndrome.
Petri M
Rheum Dis Clin North Am; 2001 Aug; 27(3):633-42, viii. PubMed ID: 11534265
[TBL] [Abstract][Full Text] [Related]
16. Thrombosis and the antiphospholipid syndrome.
Ortel TL
Hematology Am Soc Hematol Educ Program; 2005; ():462-8. PubMed ID: 16304421
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.
Levine SR; Brey RL; Tilley BC; Thompson JL; Sacco RL; Sciacca RR; Murphy A; Lu Y; Costigan TM; Rhine C; Levin B; Triplett DA; Mohr JP;
JAMA; 2004 Feb; 291(5):576-84. PubMed ID: 14762036
[TBL] [Abstract][Full Text] [Related]
18. Low recurrent thrombosis rates in single positive antiphospholipid syndrome regardless of type of anticoagulation.
Bakow BR; Yanek L; Crowther MA; Chaturvedi S
Thromb Res; 2024 May; 237():88-93. PubMed ID: 38569453
[TBL] [Abstract][Full Text] [Related]
19. [Antiphospholipid syndrome].
Arvieux J; Hachulla E
Ann Cardiol Angeiol (Paris); 2002 Jun; 51(3):146-51. PubMed ID: 12471645
[TBL] [Abstract][Full Text] [Related]
20. Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.
Cohen H; Hunt BJ; Efthymiou M; Arachchillage DR; Mackie IJ; Clawson S; Sylvestre Y; Machin SJ; Bertolaccini ML; Ruiz-Castellano M; Muirhead N; Doré CJ; Khamashta M; Isenberg DA;
Lancet Haematol; 2016 Sep; 3(9):e426-36. PubMed ID: 27570089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]